USNA SEC Filing News — USANA Health Sciences, Inc.

Latest SEC filings for USANA Health Sciences, Inc. (USNA) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-05.

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 1…
Sector: Consumer Defensive Industry: Packaged Foods Market Cap: $275.1M
20
Total Filings
0
Bullish Classifications
5
Bearish Classifications
14
Insider Transactions
2
Material Events (8-K)
1
Periodic Reports
Rule-based classifications for USNA currently lean bearish. Of the 20 filing records displayed, 5 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
USNA Filing Activity Snapshot 2026-05-29 — 2026-10-05
Insider Transactions (Form 4)
0 buys vs 5 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$129.1K
Jones Paul A. (CHIEF PEOPLE OFFICER) · 2026-05-29
6,813 shares · Form 4
Form 144 Notices
3
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 14 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 14 filings in this group are Form 4s for USANA Health Sciences, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 14 insider filings shown, the breakdown is 9 option exercise and 5 open-market sale. 5 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Option exercise ×9
The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.
Open-market sale ×5
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Form 4 Option exercise Tax / Compensation Filing 2026-07-27

USNA insider Form 4 filed for equity award, exercise, or tax withholding

Benedict Peter (CHIEF INFORMATION OFFICER) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 598 — —
F Tax withholding on vested shares 176 $21.32 $3.8K
M Option exercise derivative · Restricted Stock Units 598 — —
Filing: Form 4 (Insider Transaction) Insider: Benedict Peter (CHIEF INFORMATION OFFICER) Shares: 774
Form 4 Option exercise Tax / Compensation Filing 2026-07-27

USNA insider Form 4 filed for equity award, exercise, or tax withholding

Armstrong Kathryn Michelle (CHIEF SCIENTIFIC OFFICER) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 1,166 — —
F Tax withholding on vested shares 518 $21.32 $11.0K
M Option exercise derivative · Restricted Stock Units 1,166 — —
Filing: Form 4 (Insider Transaction) Insider: Armstrong Kathryn Michelle (CHIEF SCIENTIFIC OFFICER) Shares: 1,684
Form 4 Option exercise Tax / Compensation Filing 2026-07-27

USNA insider Form 4 filed for equity award, exercise, or tax withholding

WOOD TIMOTHY E (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 1,632 — —
F Tax withholding on vested shares 408 $20.92 $8.5K
M Option exercise derivative · Restricted Stock Units 1,632 — —
Filing: Form 4 (Insider Transaction) Insider: WOOD TIMOTHY E (Director) Shares: 2,040
Form 4 Option exercise Tax / Compensation Filing 2026-07-27

USNA insider Form 4 filed for equity award, exercise, or tax withholding

Winssinger Frederic J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 1,632 — —
M Option exercise derivative · Restricted Stock Units 1,632 — —
Filing: Form 4 (Insider Transaction) Insider: Winssinger Frederic J (Director) Shares: 1,632
Form 4 Option exercise Tax / Compensation Filing 2026-07-27

USNA insider Form 4 filed for equity award, exercise, or tax withholding

Nixon J Scott (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 1,632 — —
M Option exercise derivative · Restricted Stock Units 1,632 — —
Filing: Form 4 (Insider Transaction) Insider: Nixon J Scott (Director) Shares: 1,632
Form 4 Option exercise Tax / Compensation Filing 2026-07-27

USNA insider Form 4 filed for equity award, exercise, or tax withholding

FULLER GILBERT A (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 1,632 — —
M Option exercise derivative · Restricted Stock Units 1,632 — —
Filing: Form 4 (Insider Transaction) Insider: FULLER GILBERT A (Director) Shares: 1,632
Form 4 Option exercise Tax / Compensation Filing 2026-07-27

USNA insider Form 4 filed for equity award, exercise, or tax withholding

Pelosi Peggie (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 1,632 — —
F Tax withholding on vested shares 935 $20.92 $19.6K
M Option exercise derivative · Restricted Stock Units 1,632 — —
Filing: Form 4 (Insider Transaction) Insider: Pelosi Peggie (Director) Shares: 2,567
Form 4 Option exercise Tax / Compensation Filing 2026-07-27

USNA insider Form 4 filed for equity award, exercise, or tax withholding

Fleming John Turman (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 1,632 — —
M Option exercise derivative · Restricted Stock Units 1,632 — —
Filing: Form 4 (Insider Transaction) Insider: Fleming John Turman (Director) Shares: 1,632
Form 4 Option exercise Tax / Compensation Filing 2026-07-27

USNA insider Form 4 filed for equity award, exercise, or tax withholding

Ding Xia (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 1,632 — —
F Tax withholding on vested shares 604 $20.92 $12.6K
M Option exercise derivative · Restricted Stock Units 1,632 — —
Filing: Form 4 (Insider Transaction) Insider: Ding Xia (Director) Shares: 2,236
Form 4 Open-market sale Insider Selling 2026-06-18

USNA insider Neidig Brent (CHIEF COMMERCIAL OFFICER) sold 5,002 shares (~$97.3K)

Neidig Brent, listed as CHIEF COMMERCIAL OFFICER at USANA HEALTH SCIENCES INC, reported an open-market sale of 5,002 USNA shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 5,002 $19.45 $97.3K
Filing: Form 4 (Insider Transaction) Insider: Neidig Brent (CHIEF COMMERCIAL OFFICER) Shares: 5,002 Est. Value: $97.3K
Form 4 Open-market sale Insider Selling 2026-06-16

USNA insider Neidig Brent (CHIEF COMMERCIAL OFFICER) sold 2,511 shares (~$50.5K)

Neidig Brent, listed as CHIEF COMMERCIAL OFFICER at USANA HEALTH SCIENCES INC, reported an open-market sale of 2,511 USNA shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 1,602 $20.15 $32.3K
S Open-market sale 909 $20.00 $18.2K
Filing: Form 4 (Insider Transaction) Insider: Neidig Brent (CHIEF COMMERCIAL OFFICER) Shares: 2,511 Est. Value: $50.5K
Form 4 Open-market sale Insider Selling 2026-06-08

USNA insider Jones Paul A. (CHIEF PEOPLE OFFICER) sold 5,561 shares (~$102.9K)

Jones Paul A., listed as CHIEF PEOPLE OFFICER at USANA HEALTH SCIENCES INC, reported an open-market sale of 5,561 USNA shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 5,561 $18.50 $102.9K
Filing: Form 4 (Insider Transaction) Insider: Jones Paul A. (CHIEF PEOPLE OFFICER) Shares: 5,561 Est. Value: $102.9K
Form 4 Open-market sale Insider Selling 2026-06-01

USNA insider Fleming John Turman (Director) sold 2,450 shares (~$43.9K)

Fleming John Turman, listed as Director at USANA HEALTH SCIENCES INC, reported an open-market sale of 2,450 USNA shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 2,450 $17.93 $43.9K
Filing: Form 4 (Insider Transaction) Insider: Fleming John Turman (Director) Shares: 2,450 Est. Value: $43.9K
Form 4 Open-market sale Insider Selling 2026-05-29

USNA insider Jones Paul A. (CHIEF PEOPLE OFFICER) sold 6,813 shares (~$129.1K)

Jones Paul A., listed as CHIEF PEOPLE OFFICER at USANA HEALTH SCIENCES INC, reported an open-market sale of 6,813 USNA shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 6,813 $18.95 $129.1K
Filing: Form 4 (Insider Transaction) Insider: Jones Paul A. (CHIEF PEOPLE OFFICER) Shares: 6,813 Est. Value: $129.1K
Proposed Insider Sales 3 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. USANA Health Sciences, Inc. has 3 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-06-16

USNA Form 144 filed for proposed insider sale by BRENT LOWELL NEIDIG (5,002 shares) ~$97.3K

BRENT LOWELL NEIDIG filed a Form 144 with the SEC indicating intent to sell USNA (USANA HEALTH SCIENCES INC) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: BRENT LOWELL NEIDIG Shares: 5,002 Est. Value: $97.3K
Form 144 Proposed Insider Sale 2026-06-15

USNA Form 144 filed for proposed insider sale by BRENT LOWELL NEIDIG (909 shares) ~$18.2K

BRENT LOWELL NEIDIG filed a Form 144 with the SEC indicating intent to sell USNA (USANA HEALTH SCIENCES INC) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: BRENT LOWELL NEIDIG Shares: 909 Est. Value: $18.2K
Form 144 Proposed Insider Sale 2026-06-08

USNA Form 144 filed for proposed insider sale by PAUL A JONES (5,561 shares) ~$102.9K

PAUL A JONES filed a Form 144 with the SEC indicating intent to sell USNA (USANA HEALTH SCIENCES INC) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: PAUL A JONES Shares: 5,561 Est. Value: $102.9K
Material Events 2 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 2 in this period for USANA Health Sciences, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-10-05

USNA filed 8-K — material company event

USANA HEALTH SCIENCES INC filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-08-04

USNA filed 8-K — material company event

USANA HEALTH SCIENCES INC filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 quarterly report (10-Q) for USANA Health Sciences, Inc.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-13

USNA filed Quarterly Report (10-Q)

USANA HEALTH SCIENCES INC filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)

How we classify USANA Health Sciences, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on USNA. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — USNA SEC Filings

More Tools for USNA

Want deeper USNA analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the USNA stock analysis page.

USNA Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer